Stocks to Watch: 5 Big Earnings Reports July 24
Meta description: Stocks to watch before the bell on July 24, 2026: Amex, Charter, Tenet, HCA, and CN Rail all report Q2 earnings. Here's what matters for each.
Friday mornings during earnings season have a specific kind of chaos to them, and July 24, 2026 is shaping up to be one of the busier ones. Before the opening bell, we've got five companies reporting across four completely different corners of the economy — payments, cable and broadband, hospitals (twice), and freight rail. That's a genuinely useful cross-section if you're trying to get a read on consumer spending, healthcare utilization, and industrial activity all in one morning.
I'll say this upfront: I'm not going to pretend every name on this list is equally exciting. American Express is the marquee report of the bunch. Charter is the one with the most drama attached to it. And Canadian National Railway is the quiet one that freight-watchers actually care about more than the headlines suggest. But if you own any of these, or you're using earnings season as a broader read on where the economy stands, all five are worth ten minutes of your attention.
Here's what's on deck, why it matters, and what I'd be watching for in each report.
These 6 Stocks Could Help Build Monthly Passive Income
Key Takeaways
- American Express (AXP) reports Q2 EPS expectations around $4.41, an 8% jump year-over-year, with revenue growth pegged near 19-20% — a genuinely strong number if it holds.
- Charter Communications (CHTR) is the highest-drama name here: the stock is down roughly two-thirds over the past year on broadband subscriber losses, and this quarter is complicated by the pending $34.5 billion Cox Communications merger.
- Tenet Healthcare (THC) has beaten earnings estimates in every quarter over the trailing year, with an average surprise north of 20% — a genuinely impressive streak that sets a high bar.
- HCA Healthcare (HCA) trades at a premium to its own hospital-sector peers, and analysts are looking for confirmation that patient volumes and payer mix are holding up.
- Canadian National Railway (CNI) is a read on freight demand and industrial activity, with analysts turning more constructive recently on rising volumes and tightening rail capacity.
- None of these reports happen in a vacuum — they land the same week as broader market jitters over AI capex spending and a hawkish shift in Fed rhetoric, so context matters as much as the individual numbers.
American Express (AXP): The One Everyone's Watching
Let's start with the big one. American Express reports its second quarter results before the bell, and the setup here is genuinely interesting — not because anyone expects a disaster, but because the bar has been quietly rising all year.
Consensus estimates call for EPS of roughly $4.41, which would represent about an 8% increase from the year-ago quarter. Revenue expectations are even more eye-catching, with some estimates pointing toward 19-20% year-over-year growth — a number that, if accurate, would be a meaningful acceleration from the mid-single-digit to low-double-digit growth many legacy financial companies are putting up these days.
Why Amex Is Different From a Typical Bank
Here's something I think gets underappreciated about Amex: it's not really a bank in the traditional sense, even though it has a banking arm. Its core business model — issuing premium cards to higher-income, lower-credit-risk customers and charging merchants a swipe fee — makes it less exposed to interest rate swings than you'd assume. Declining rates tend to help by boosting consumer spending; rising rates can actually help the banking side of the business through higher net interest income. That dual exposure is part of why Amex has historically been treated as a bit of a "have your cake and eat it too" stock in the payments space.
That said, the stock hasn't been a straight line higher this year — shares dipped roughly 4% after the April Q1 report even though both revenue and EPS beat estimates, a reminder that "meeting the number" isn't always enough when a stock is priced for perfection. Amex's Zacks-derived 2026 P/E sits meaningfully above the broader industry average, which the data suggests reflects the market pricing in higher relative earnings growth than peers. That's a real signal, but it also means less room for error.
What I'm Watching
- Card member spending trends — this is the single most important line item. Any softening here would ripple across the whole discretionary-spending narrative for the rest of earnings season.
- Credit quality metrics — delinquency and write-off rates. Amex's customer base skews affluent, which has historically insulated it somewhat from consumer credit stress, but it's not immune.
- Full-year guidance — management has previously guided to a healthy EPS range for the year; any tweak up or down will move the stock more than the quarterly beat or miss itself.
Price Levels to Watch: Support & Target
- Recent trading range: roughly $335 (50-day moving average) to $363 heading into the print, with the stock consolidating just under its 52-week highs.
- Near-term support: the $335–$346 zone (50-day moving average) is the first level bulls would want held on any post-earnings dip; a break below opens the door toward the $313–$323 area.
- Analyst price targets: consensus sits around $365–$372 (average of ~36 analysts), with the more bullish models (Piper Sandler, 24/7 Wall St.) pointing toward $390–$396 if the quarter confirms strong billings growth and credit quality holds up.
- My read: this is a "beat-and-hold-guidance" setup — the stock likely needs a clean beat plus reaffirmed or raised full-year guidance to push meaningfully past resistance; a mere in-line quarter could see it drift back toward the support zone.
EPS Scenario: What a Beat, Miss, or In-Line Print Could Mean
- Consensus estimate: ~$4.41, representing 8% year-over-year growth.
- Recent track record: Amex missed consensus by roughly -0.28% in Q4 2025, but had beaten estimates in the three quarters before that — a generally solid, if not spotless, history.
- If it beats: given how tightly priced this stock already is heading into the print, a beat alone probably isn't enough. The market will want to see strong card member spending trends and stable credit quality alongside the number before rewarding the stock with a move toward resistance.
- If it misses: even a small miss could trigger an outsized reaction, since expectations are already elevated and the stock trades at a premium multiple to the broader industry.
- If it's in-line: attention shifts almost entirely to guidance — a reaffirmed or raised full-year EPS range would likely matter more than the quarterly number itself.
Charter Communications (CHTR): The Turnaround Story
Nobody's Sure About Yet
If Amex is the steady hand, Charter Communications is the wild card. This is genuinely one of the more dramatic earnings setups of the week, and I think it deserves more attention than it's getting outside of media-focused investing circles.
The headline numbers: consensus EPS estimates cluster somewhere in the $9.96 to $10.24 range, representing roughly 8-12% year-over-year growth depending on which estimate set you use. But here's the thing — Charter has missed Wall Street's EPS estimates in each of the past four quarters, with an average negative surprise approaching 7%. That's not a great track record heading into a report, and it's part of why the stock's reaction to earnings has been so volatile lately.
The Broadband Subscriber Problem
The core issue at Charter isn't really about a single quarter's numbers — it's a structural question about whether cable broadband can keep competing with fiber overbuild and fixed wireless alternatives from AT&T, Verizon, and T-Mobile. Charter's Q1 2026 report showed the company shed 120,000 broadband subscribers, worse than the roughly 100,000 the Street expected, and the stock cratered more than 25% in a single session on that news. That's the kind of move that resets an entire investment thesis, and it's why shares have fallen roughly two-thirds over the trailing 52 weeks even as the broader market has climbed.
The Cox Merger Wildcard
Layered on top of the subscriber story is Charter's pending $34.5 billion acquisition of Cox Communications, expected to close sometime this summer, along with an $11.4 billion capital expenditure plan to modernize its network through 2027. This is a genuinely consequential deal — if management can convert it into real synergies (some estimates point to roughly $800 million), it could reshape the long-term competitive picture. But mergers this size also mean elevated leverage in the near term, and analysts have flagged Charter's debt levels as a real point of concern while the deal works through final regulatory approval.
There was also a notable pop in Charter shares back in late June after reports that the company had discussed a satellite-powered consumer phone service with SpaceX — a reminder that this stock can move sharply on news that has nothing to do with the quarterly numbers at all.
What I'm Watching
- Broadband net additions or losses — the single most important number in this report, full stop.
- Mobile line growth — Charter's convergence strategy (bundling mobile with broadband) has been one of its few genuine bright spots, though even that growth appears to be decelerating as competitors ramp up device subsidies.
- Commentary on the Cox deal timeline and any update on regulatory clearance.
- Free cash flow trends, given how much capital is being poured into network upgrades right now.
Price Levels to Watch: Support & Target
- Recent trading range: shares have been swinging between roughly $124 and $131 in the days leading into the report, well off the 52-week high near $398.74 set before the subscriber-loss collapse.
- Near-term support: the $115–$120 zone is the level to watch on a disappointing print — a clean break below that would put the stock in fresh multi-year-low territory.
- Near-term resistance: roughly $140–$150, the range the stock struggled to reclaim after its April crash.
- A word of caution on "targets": you'll see older analyst price targets floating around in the $300–$395 range online — these are largely stale, dating from before this year's subscriber-loss collapse, and haven't caught up to the new reality. I'd ignore them until analysts formally re-rate the stock post-earnings; the more relevant near-term battle is the $115–$150 range described above.
- My read: this is the most binary setup of the five. A subscriber-loss number better than feared, paired with reassuring Cox-merger commentary, could spark a sharp relief rally given how beaten-down sentiment already is. A miss, especially on broadband adds, likely pressures the stock back toward support.
EPS Scenario: What a Beat, Miss, or In-Line Print Could Mean
- Consensus estimate: roughly $9.96–$10.24, representing 8-12% year-over-year growth depending on the estimate set used.
- Recent track record: this is the red flag of the group — Charter has missed consensus in each of the past four quarters, with an average negative surprise near -6.95%.
- If it beats: given a four-quarter miss streak and how far sentiment has already fallen, even a modest beat — especially paired with better-than-feared broadband subscriber losses — could spark a sharp relief rally.
- If it misses (again): a fifth consecutive miss would be a much bigger red flag than a single bad quarter, and could reasonably push the stock toward fresh multi-year lows, particularly if Cox-merger uncertainty adds to the pressure.
- If it's in-line: the subscriber and mobile-line trends will matter more than the EPS figure itself — a stabilizing broadband loss number would likely be read as a bigger win than the headline EPS beating or missing by a few cents.
I'll be honest — this is a name where I'd want to see the actual subscriber trend line before forming a strong opinion either way. The valuation looks cheap on a headline P/E basis, but cheap stocks can stay cheap (or get cheaper) when the underlying business is genuinely challenged.
These 6 Stocks Could Help Build Monthly Passive Income
Tenet Healthcare (THC): A Streak Worth Paying Attention To
Moving into healthcare, Tenet Healthcare brings one of the more impressive recent track records in this group. Consensus estimates call for EPS around $4.08 to $4.26, and the company has beaten consensus in every single quarter over the past year, including one standout quarter where it topped estimates by nearly 15%.
That's a genuinely strong streak, and it's part of why the stock has been climbing into the print even as some analysts trim their price targets. That combination — rising share price alongside cautious analyst commentary — often sets up what I'd call a "battleground" earnings report: the bar is high, sentiment is generally positive, but there's real skepticism baked into individual price targets.
What's Driving the Caution
Analyst commentary heading into the quarter has flagged flat hospital revenue and softer surgical volumes across the sector, partially offset by strength in medical (non-surgical) volumes. This isn't necessarily a Tenet-specific problem — it reflects broader trends across hospital operators — but it does mean the "beat" this quarter may come more from cost discipline and mix than from blowout volume growth.
Tenet's business mix, which leans more heavily into ambulatory surgery centers and outpatient services than some pure hospital peers, is often cited as a structural advantage here. That diversification can smooth out some of the lumpiness in inpatient hospital volumes.
What I'm Watching
- Admissions, surgical case counts, and ED traffic — the core volume metrics that drive the whole business.
- Ambulatory segment performance — this is where Tenet's diversification story either proves itself or doesn't.
- Full-year guidance updates, given that the current consensus full-year EPS estimate implies solid mid-single-digit growth for 2026.
Price Levels to Watch: Support & Target
- Recent trading range: shares were around $195 heading into the report, near the upper end of a multi-month uptrend.
- Near-term support: the $190 level (former resistance turned support) is the first line of defense on a pullback; below that, the low-$180s would be the next area to watch.
- Resistance/upside targets: roughly $210, then $230–$235 — matching where Bank of America ($210) and TD Cowen ($233) have set their price targets even after trimming them slightly this month.
- My read: with a nearly spotless beat streak already priced in, THC needs more than just "another beat" — the market will be looking for confirmation that volume trends haven't cracked. A clean beat likely tests the $210 zone; anything short of that risks a pullback toward the $190 support shelf.
EPS Scenario: What a Beat, Miss, or In-Line Print Could Mean
- Consensus estimate: figures vary by source, clustering between $4.08 and $4.26, representing anywhere from roughly 1.5% to nearly 36% year-over-year growth depending on which estimate set is used — worth double-checking against the final consensus closer to the print.
- Recent track record: Tenet has beaten estimates in every quarter over the trailing year, with an average surprise north of 20%, including a standout quarter where it topped estimates by nearly 15%.
- If it beats: given how strong the beat streak already is, the market's bar has shifted from "will they beat" to "by how much." A large beat could push the stock toward the $210 resistance zone.
- If it misses: this would be the first miss in over a year, and could trigger an outsized negative reaction precisely because the streak has conditioned the market to expect a beat every time.
- If it's in-line: admissions, surgical case counts, and ambulatory segment performance will likely matter more than the EPS number itself in determining the stock's direction.
HCA Healthcare (HCA): The Premium-Priced Bellwether
HCA Healthcare is the largest and arguably most closely watched hospital operator in the country, which makes its report a useful bellwether for the entire space — even beyond whatever happens with its own stock.
Consensus estimates land around $7.57 per share, representing roughly 10-11% year-over-year growth. That's a healthy number, and it comes against a backdrop where HCA trades at a premium multiple relative to hospital sector peers — a valuation gap that reflects the market's view that HCA has structural scale advantages most smaller operators don't.
The Setup Into the Print
Interestingly, HCA shares have actually lagged the broader healthcare providers group over the past month, even as sentiment across the sector has generally improved. That's created a situation where the stock is heading into earnings trading below its average analyst price target by a fairly wide margin — the kind of gap that either closes on a strong report or widens further if results disappoint.
HCA has a mixed recent track record — beating estimates in three of its last four quarters while missing narrowly in one — so this isn't a company with the same eye-popping beat streak as Tenet. That said, it's also a business with genuine scale advantages: broad geographic diversification, strong negotiating leverage with payers, and a long history of disciplined capital allocation.
What I'm Watching
- Revenue growth relative to guidance — the market is looking for roughly 6% top-line growth, matching the pace from a year ago.
- Payer mix trends, especially any commentary on Medicaid or exchange-related volume shifts given ongoing policy debates around healthcare coverage.
- Capital allocation commentary — HCA has historically been aggressive with buybacks, and any change in that posture would be noteworthy.
Price Levels to Watch: Support & Target
- Recent trading range: shares were trading around $373–$374 heading into the print, down modestly over the past month even as the broader hospital sector rallied.
- Near-term support: the $350–$360 zone is a reasonable area to watch on a disappointing report, roughly where the stock has found buyers over the past few months.
- Near-term resistance: roughly $390–$400, an area the stock has struggled to clear over the past month even as sector sentiment improved.
- Analyst price targets: the average sits somewhere between $467 and $493, implying meaningful upside from current levels — a wide gap that reflects genuine optimism about HCA's scale advantages, but also means the stock is leaning on the report to help close that distance.
- My read: HCA's setup is less binary than Charter's but still meaningful — given how far the stock trades below its own average target, a solid beat with steady guidance could be the catalyst for a re-rating higher. A miss, on the other hand, likely just keeps the stock rangebound rather than triggering a sharp selloff, since expectations are more measured than for Tenet.
EPS Scenario: What a Beat, Miss, or In-Line Print Could Mean
- Consensus estimate: figures cluster between $7.37 and $7.57, representing roughly 7.8% to nearly 11% year-over-year growth depending on the source.
- Recent track record: HCA missed consensus by about -0.28% in Q1 2026, but has beaten estimates in three of its last four quarters overall — a solid but not flawless history.
- If it beats: with the stock trading well below its average analyst target, a beat paired with confident guidance could be the trigger for a re-rating toward the $390–$400 resistance zone and beyond.
- If it misses: given HCA's more measured expectations relative to Tenet's beat streak, a miss likely just keeps the stock rangebound near current levels rather than causing a sharp selloff, unless it's accompanied by weak payer-mix or volume commentary.
- If it's in-line: revenue growth relative to the roughly 6% guided pace, along with capital allocation commentary, will likely carry more weight than the EPS figure alone.
Canadian National Railway (CNI): The Quiet Industrial Read
Last but not least, Canadian National Railway rounds out the list, and I'd actually encourage you not to skip past this one just because rail stocks don't generate the same headlines as consumer or healthcare names.
Consensus EPS estimates sit around $1.39, representing roughly 3% year-over-year growth — modest compared to the double-digit growth expected from some of the other names on this list, but freight rail is a different kind of business, more tied to broader industrial and trade volumes than to consumer discretionary spending.
Why Analysts Have Gotten More Constructive
What's notable here is the recent shift in analyst tone. Multiple firms have raised price targets on CN ahead of this report, citing stronger transport earnings expectations driven by improving domestic and international freight demand alongside tightening rail capacity. That's a meaningfully more optimistic setup than CN faced earlier in the year, when the company was dealing with an estimated $350 million in revenue headwinds from tariffs and had guided toward roughly flat volumes for 2026.
CN also set a monthly grain-movement record in June, moving nearly 2.7 million metric tonnes of grain from Western Canada — a data point that, while narrow, supports the broader narrative of improving freight volumes heading into the print.
What I'm Watching
- Volume trends across key freight categories — grain, intermodal, petroleum, and forest products all tell slightly different stories about where industrial demand is heading.
- Commentary on tariff-related headwinds — whether the roughly $350 million impact flagged earlier in the year is stabilizing, worsening, or improving.
- Capital return updates — CN has been active with both dividends and buybacks, and management's tone on continued capital return will matter for the stock's near-term trajectory.
Price Levels to Watch: Support & Target
- Recent trading range: shares were trading around $127–$131 heading into the report, near the top of their 52-week range (roughly $90.74–$131.12).
- Near-term support: the $120 level is a reasonable zone to watch on any post-earnings weakness, roughly matching Stephens' more cautious price target.
- Near-term resistance: the $131–$135 zone, right around the stock's current 52-week high, is the first hurdle before the more bullish $141 target comes into play.
- Analyst price targets: a fairly tight cluster between $109 (Barclays) on the cautious end and $141 (Citi) on the bullish end, with RBC's C$195 target (roughly equivalent once converted from Canadian dollars) landing near the higher end too.
- My read: the target spread here is narrower than the other four names, which tells you analysts are relatively aligned — this isn't a stock priced for a dramatic surprise in either direction. A beat on freight volumes, paired with confident commentary on tariff headwinds easing, could push shares toward the $140 area; a miss likely just pulls it back toward the $120 support zone rather than triggering a sharp break.
EPS Scenario: What a Beat, Miss, or In-Line Print Could Mean
- Consensus estimate: approximately $1.39, representing about 3% year-over-year growth — modest compared to the double-digit growth expected elsewhere on this list.
- Recent track record: CN missed consensus by roughly -1.46% in the Q2 2025 comparison period, a relatively small miss.
- If it beats: railroad stocks tend to react less violently to EPS surprises than tech or consumer names — a beat paired with confirmation of improving freight volumes and easing tariff headwinds would likely matter more than the EPS figure itself, and could support a push toward the $131–$135 resistance zone.
- If it misses: given the already-modest growth expectations, a miss probably won't be treated as a major shock unless it's accompanied by weaker guidance on freight volumes or a worsening tariff impact.
- If it's in-line: commentary on grain, intermodal, and petroleum volume trends, along with capital return plans, will likely drive the stock's reaction more than the headline EPS number.
Quick Valuation Snapshot: How These Five Stack Up
Before diving into the bigger picture, it's worth pausing on how differently the market is currently pricing these five names — because the valuation gap here is unusually wide for companies reporting the same week.
Amex trades at a clear premium to the broader financial services industry on a forward P/E basis, which reflects the market's expectation of above-peer earnings growth — but that also means less room for disappointment. Charter, by contrast, trades at a notably discounted multiple relative to its own industry, a reflection of genuine skepticism about the durability of its broadband business even with the Cox deal in the pipeline. That's the kind of gap where being "right" about the underlying business matters far more than simply comparing headline P/E ratios.
On the healthcare side, Tenet's valuation sits closer to peer averages despite its strong beat streak, while HCA commands enough of a scale premium that some analysts see room for the stock to re-rate higher if it simply meets expectations. Canadian National, meanwhile, trades at a premium to its own transportation peers — a reflection of its historically wide operating margins and strong free cash flow generation relative to trucking and other rail competitors.
The broader takeaway I'd draw from this: cheap doesn't always mean undervalued, and expensive doesn't always mean overpriced. Context — competitive position, growth durability, and balance sheet strength — matters more than the raw multiple on its own.
The Bigger Picture: Why This Earnings Batch Matters Beyond
the Individual Stocks
I think it's worth zooming out for a second. These five reports land in the middle of a genuinely turbulent stretch for the broader market — one where AI capex anxiety and a more hawkish Fed tone have already produced some sharp single-day selloffs this month. None of these five companies are directly tied to the AI infrastructure story, which is exactly why I think they're useful diagnostic tools right now.
American Express gives you a read on consumer spending health, independent of the tech-sector narrative dominating headlines. Charter gives you a read on cable and broadband competitive dynamics, which matters for the whole communications sector regardless of what's happening in AI. The two hospital names give you a read on healthcare utilization trends, which tend to be relatively insulated from macro swings but not immune to labor cost pressures. And Canadian National gives you a genuinely useful industrial and freight demand signal — arguably one of the more reliable "real economy" indicators available, since railroads move actual physical goods rather than trading on sentiment.
If several of these reports come in weak at the same time, that's a different and arguably more concerning signal than a single disappointing tech earnings report, because it would suggest broader economic softening rather than a sector-specific issue.
These 6 Stocks Could Help Build Monthly Passive Income
How to Approach Earnings Week as a Retail Investor
A few practical thoughts, separate from the stock-specific analysis above.
- Don't trade the headline number alone. As we've seen with Amex's April report, a beat on both revenue and EPS doesn't guarantee a positive stock reaction if expectations were already elevated.
- Pay attention to guidance more than the trailing quarter. Markets are forward-looking; a good quarter with cautious forward commentary often gets punished more than a mediocre quarter with confident guidance.
- Watch the after-hours and pre-market reaction, but don't overreact to it. Initial moves on earnings days are frequently exaggerated by thin trading volume and can reverse once the broader market has a chance to digest the details on the call.
- Separate company-specific news from sector-wide moves. Charter's stock swings, for instance, are often driven as much by merger-related headlines as by the underlying subscriber trends — know which one you're actually reacting to.
- Use earnings season as a diversification check. If your portfolio is heavily concentrated in one of these sectors, this week is a good moment to ask whether that concentration still matches your risk tolerance.
About the Data
Earnings estimates, historical beat/miss rates, and valuation figures referenced in this article reflect consensus analyst data and publicly available reporting as of the time of writing, ahead of the July 24, 2026 reports. Actual results, along with any related stock price moves, should be verified against company press releases and primary financial sources once reported — pre-earnings estimates can shift right up until the print, and this article does not reflect the actual reported results.
Frequently Asked Questions
1. What time do most companies report earnings before the market opens?
Companies reporting "before the bell" typically release results between 6:00 and 8:00 a.m. Eastern Time, with conference calls usually following around 8:00-8:30 a.m., ahead of the 9:30 a.m. market open.
2. Why does Charter Communications stock react so strongly to earnings?
Charter's stock has been highly sensitive to broadband subscriber trends, since that metric is viewed as the clearest signal of whether the company can compete against fiber and fixed wireless alternatives. Combined with an active, large-scale merger (Cox Communications) currently in progress, there are multiple catalysts that can move the stock sharply in either direction.
3. Is American Express considered a bank stock or a payments stock?
It's genuinely both. Amex operates a lending and banking business alongside its core card-issuing and payments network, which gives it a somewhat unique risk profile compared to pure-play payment networks or traditional regional banks.
4. How reliable are hospital company earnings as an economic indicator?
Healthcare utilization tends to be less directly tied to macroeconomic swings than consumer discretionary spending, but it's not fully insulated — labor costs, payer mix, and patient volume trends can still shift meaningfully with broader economic conditions and policy changes.
5. Why do analysts care about railroad earnings for reading the broader economy?
Railroads move physical freight — grain, intermodal containers, petroleum products, and more — which makes their volume trends a fairly direct reflection of industrial activity and trade flows, independent of stock market sentiment.
6. Should I buy a stock right before its earnings report?
This isn't something I'd recommend as a blanket strategy. Earnings introduce a binary, hard-to-predict event into your position, and even companies with strong beat histories can see their stock fall on a good quarter if guidance disappoints or if the stock was already priced for perfection.
Wrapping It Up
Five very different businesses, one very busy Friday morning. If I had to rank what I'm personally most curious about, it's Charter — simply because there's a real story playing out there beyond the quarterly number, between the subscriber losses and the Cox merger. But Amex is the one that probably matters most for the broader "how's the consumer doing" narrative, and CN Rail is the one I'd watch if you want a read on the industrial economy that has nothing to do with AI spending headlines.
Which of these five are you watching most closely, and are you holding any of them into the print? Let me know in the comments. And if this kind of earnings-week breakdown is useful, consider subscribing so you don't miss the next one.
These 6 Stocks Could Help Build Monthly Passive Income
Post a Comment